Some 55,000 doses of the vaccine manufactured by Anglo-Swedish company AstraZeneca and shipped to the Czech Republic are set to expire by the end of October, Czech radio station IROZHLAS reported. While about 10,000 of them are expected to be used to administer second doses, the remaining batches might have to be incinerated if the demand for the jab fails to shoot up.
So far, it has been at rock bottom. According to the data cited in the report, only 36 people have chosen AstraZeneca for their first dose in September, and a total of 774 people have been vaccinated with it so far.
During July and August, only about 1,200 of those newly vaccinated opted for AstraZeneca’s vaccine, a tiny fraction of the 860,000 people who applied for their first dose within that period.
More than 14,000 doses of AstraZeneca’s vaccine were thrown away in the past month alone due to the lack of interest from the public, Czech media reported.
Its apparent lack of popularity has been blamed on the fact that since June, the Czech health ministry has recommended that the AstraZeneca and Johnson & Johnson Covid-19 vaccines only be given to those older than 60. The precaution was introduced after the vaccines were suspected of causing potentially deadly blood clots detected in some younger people after they received the jab. Although the cases are reported to be rare, several countries, including the Czech Republic, limited or halted the use of the vaccine.